Gene · 84823
LMNB2: lamin B2
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. LMNB2: lamin B2. Genes, record 84823. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/84823
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q03252 | Lamin-B2 | 620 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents13
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 5701 | Q03252 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4998 | Q03252 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 5701 | Q03252 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 4998 | Q03252 | Espacenet |
| US 11773371 B2 | 2023-10-03 | 26 | Q03252 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 44930 | Q03252 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 147901 | Q03252 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 6259 | Q03252 | Espacenet |
| US 10155008 B2 | 2018-12-18 | 4 | Q03252 | Espacenet |
| WO 2018138478 A1 | 2018-08-02 | 26 | Q03252 | Espacenet |
1 to 10 of 13
See all 13 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants923
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | LMNB2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 11 | 2025 |
| ZIABC010411 | Initiation of DNA Replication in Mammalian Cells | 7 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 5 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 4 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 4 | 2025 |
| ZIABC010309 | Nuclear Architecture and Disease | 4 | 2025 |
| ZIAHG200305 | Hutchinson-Gilford Progeria syndrome--a model for the genetics of aging. | 4 | 2025 |
| P20GM103432 | Wyoming IDeA Networks for Biomedical Research Excellence Phase 4 | 3 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 3 | 2025 |
| P30CA023168 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 923Source NIH's project files
See all 923 nih grantsPapers1,344
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lamin B1 coordinates the assembly of the nuclear lamina. | J Cell Sci | 2026 | 42781858 | PubTator, text mining | PubMed |
| Identification of disulfidptosis-related molecular subtypes in pleural mesothelioma demonstrates a correlation with the immune infiltration, prognosis and therapy efficacy. | Discov Oncol | 2026 | 42627616 | PubTator, text mining | PubMed |
| Combinatorial post-translational modification reprogramming of the endomembrane system in colorectal cancer. | Transl Cancer Res | 2026 | 42445424 | PubTator, text mining | PubMed |
| Identification of GADD45B, HMGB3, LMNB2, and MFAP5 as lactylation-related prognostic markers for survival prediction in esophageal cancer. | Transl Cancer Res | 2026 | 42445420 | PubTator, text mining | PubMed |
| Common pathogenic mechanisms in the hippocampus across neurodegenerative dementias: Alzheimer's disease, Down syndrome, and Parkinson's disease. | NPJ Dement | 2026 | 42078116 | PubTator, text mining | PubMed |
| Integrative Bioinformatic Analysis Identifies Key Genes Driving Breast Cancer Brain Metastasis. | Diagnostics (Basel) | 2026 | 42072775 | PubTator, text mining | PubMed |
| Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2. | Oncol Res | 2026 | 42065077 | PubTator, text mining | PubMed |
| Tau oligomerization induces nuclear lamina invagination and chromatin remodeling in Alzheimer's disease. | Acta Neuropathol | 2026 | 42017968 | PubTator, text mining | PubMed |
| LMNB2 promotes prostate cancer progression and epithelial-mesenchymal transition via the Wnt/β-catenin pathway. | Discov Oncol | 2026 | 42012624 | PubTator, text mining | PubMed |
| Nuclear Lamins: A Molecular Bridge Coupling Extracellular Mechanical Cues to Intranuclear Signal Transduction and Gene Regulation. | Int J Mol Sci | 2026 | 41977436 | PubTator, text mining | PubMed |
1 to 10 of 1,344
See all 1,344 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/84823
GET https://conductscience.org/api/genes/v1/84823/patents